Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.

Yi Zheng, Samuel Obeng, Bethany A Reinecke, Chongguang Chen, Palak S Phansalkar, David M Walentiny, Phillip M Gerk, Lee-Yuan Liu-Chen, Dana E Selley, Patrick M Beardsley, Yan Zhang

European journal of pharmacology 2019 Dec 15

filter terms:

For thousands of years opioids have been the first-line treatment option for pain management. However, the tolerance and addiction potential of opioids limit their applications in clinic. NFP, a MOR/KOR dual-selective opioid antagonist, was identified as a ligand that significantly antagonized the antinociceptive effects of morphine with lesser withdrawal effects than naloxone at similar doses. To validate the potential application of NFP in opioid addiction treatment, a series of in vitro and in vivo assays were conducted to further characterize its pharmacological profile. In calcium mobilization assays and MOR internalization studies, NFP showed the apparent capacity to antagonize DAMGO-induced calcium flux and etorphine-induced MOR internalization. In contrast to the opioid agonists DAMGO and morphine, cells pretreated with NFP did not show apparent desensitization and down regulation of the MOR. Though in vitro bidirectional transport studies showed that NFP might be a P-gp substrate, in warm-water tail-withdrawal assays it was able to antagonize the antinociceptive effects of morphine indicating its potential central nervous system activity. Overall these results suggest that NFP is a promising dual selective opioid antagonist that may have the potential to be used therapeutically in opioid use disorder treatment. Copyright © 2019 Elsevier B.V. All rights reserved.

Citation

Yi Zheng, Samuel Obeng, Bethany A Reinecke, Chongguang Chen, Palak S Phansalkar, David M Walentiny, Phillip M Gerk, Lee-Yuan Liu-Chen, Dana E Selley, Patrick M Beardsley, Yan Zhang. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European journal of pharmacology. 2019 Dec 15;865:172812